Donor Lymphocyte Infusion

What Donor Lymphocyte Infusion Means

Donor lymphocyte infusion, often called DLI, is a treatment used mainly for blood cancers. It involves giving a patient white blood cells called lymphocytes from a donor. This donor is usually the same person who provided stem cells for a previous transplant. The goal is to help the patient’s immune system fight any cancer cells that remain after the transplant.

Why Donor Lymphocyte Infusion Can Matter in Cancer Care

After a stem cell transplant, some patients may experience a return of their cancer. Before treatments like DLI were developed, options were limited and often involved risky second transplants. DLI offers a way to boost the immune system by adding donor immune cells that can recognize and attack cancer cells. This process is called the graft-versus-tumor effect. It has been used successfully in cancers such as chronic myelogenous leukemia (CML) and myeloma, helping some patients achieve remission.

What Patients Might See or Experience

Patients may hear about DLI when discussing treatment options after a stem cell transplant. Sometimes chemotherapy is given first to reduce cancer cells before the infusion. The infusion itself involves receiving donor white blood cells through a vein, similar to a blood transfusion. Side effects can include graft-versus-host disease, where donor cells attack healthy tissues, and lowered bone marrow function, which can increase infection risk. Patients should talk with their care team about what to expect and how side effects will be managed.

Where Donor Lymphocyte Infusion Might Appear in Care

You might see DLI mentioned in your medical records, treatment plans, or clinic notes if you have had a stem cell transplant and your cancer has returned. It may also come up in discussions about clinical trials or new therapies. Understanding that DLI is part of a broader treatment approach helps patients and caregivers ask informed questions and understand the goals of care.

What Donor Lymphocyte Infusion Does Not Automatically Mean

Seeing the term DLI does not mean a patient has a specific diagnosis or that this treatment is planned or recommended. It simply refers to a procedure that may be considered in certain situations. Each patient’s care is unique, and whether DLI is appropriate depends on many factors including the type of cancer, overall health, and previous treatments.

How to Use This Information and Next Steps

This explanation is meant to help you understand what donor lymphocyte infusion is and why it might be part of cancer care. It is not a treatment recommendation. If you see this term in your medical records or hear it from your care team, the best next step is to ask how it relates to your specific situation. Your healthcare providers can explain the benefits, risks, and alternatives based on your individual needs.